Status:

COMPLETED

FujiLAM Prospective Evaluation Trial

Lead Sponsor:

Foundation for Innovative New Diagnostics, Switzerland

Collaborating Sponsors:

Centre for Infectious Disease Research in Zambia

Infectious Diseases Institute, Uganda

Conditions:

Diagnosis of Tuberculosis in People Living With HIV

Eligibility:

All Genders

18+ years

Brief Summary

This is a prospective, multicentre cohort study in which the accuracy and the diagnostic yield of the FujiLAM test will be assessed using a microbiological reference standard, an extended microbiologi...

Eligibility Criteria

Inclusion

  • Adult PLHIV (≥18 years), irrespective of their CD4 count and antiretroviral therapy (ART) status, at risk of having pulmonary and/or extra-pulmonary TB
  • Inpatients: irrespective of TB symptoms
  • Outpatients: at least one of the symptoms suggestive of TB (as defined by WHO\*)
  • written informed consent
  • willingness to have a trial follow-up visit at 2-3 and 6 months after enrolment (e.g. not planning to relocate)

Exclusion

  • Current anti-TB treatment \*
  • Any anti-TB treatment within 60 days prior to enrolment
  • Any isoniazid preventive therapy within 6 months prior to enrolment \* Patients starting anti-TB treatment at the time of enrolment will not be excluded from the trial provided that all trial specimens are collected before starting the 3rd dose of treatment.

Key Trial Info

Start Date :

December 13 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2021

Estimated Enrollment :

1731 Patients enrolled

Trial Details

Trial ID

NCT04089423

Start Date

December 13 2019

End Date

December 31 2021

Last Update

January 25 2022

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Malawi-Liverpool-Wellcome Trust Clinical Research Programme

Blantyre, Malawi, Box 30096

2

CIDRI-Africa University of Cape Town

Cape Town, South Africa, 7925

3

Ifakara Health Institute

Dar es Salaam, Tanzania, Box 78 373

4

The HIV Netherlands Australia Thailand Research collaboration

Bangkok, Bankok, Thailand